受磷蛋白,phospholamban
1)phospholamban受磷蛋白
1.Effects of hypoxia preconditioning and praeruptorin C preconditioning on phospholamban phosphorylation in rat cardiomyocytes;缺氧预适应和前胡丙素预处理对心肌受磷蛋白磷酸化水平的影响
2.Effect of Astragalus membranaceus on sarcoplasmic reticulum phospholamban and Ca~(2+)-ATP ase in the myocardium in spontaneously hypertensive rats;黄芪对自发性高血压大鼠心肌受磷蛋白和肌浆网钙泵表达的影响
3.Research on Inhibition of Phospholamban Gene Expression with RNA Intrference Therapy for Chronic Heart Failure Rats;利用RNA干扰技术抑制受磷蛋白基因表达治疗慢性心力衰竭大鼠的研究
英文短句/例句

1.The Structure of Phospholamban and Its Md Simulations受磷蛋白的空间结构及其分子动力学模拟
2.Phospholamban Mutations in Chinese Patients with Dilated Cardiomyopathy;中国人受磷蛋白基因突变与扩张型心肌病的关系研究
3.Study on the Mechanisms of Phosphorylation in Morphine Tolerance and Dependence;吗啡耐受依赖的蛋白磷酸化机制研究
4.Effect of G Protein βγ Subunitson Phosphorylation of G-protein Coupled ReceptorsG蛋白βγ亚基影响G蛋白偶联受体磷酸化的作用研究
5.Effect of G Protein βγ Subunits on Phosphorylation of M2 ReceptorG蛋白β、γ亚基对M2受体的磷酸化的影响
6.The Expression of PTPRO Gene Was Regulated by MiR-17-92 Cluster;受体型蛋白酪氨酸磷酸酶O(PTPRO)基因的表达受MiR-17-92簇调控
7.Research on Tyrosine Phosphorylation of Leptin Receptors in Experimental Fatty Liver and Hepatic Cirrhosis;实验性大鼠脂肪肝及肝硬化瘦素受体蛋白酪氨酸磷酸化研究
8.Immunological Evidence of the IP_3R-Like Protein in Oryza Sativa and Arabidopsis Thaliana;水稻和拟南芥中类三磷酸肌醇受体蛋白的免疫学证据
9.Effects of asPLB Gene Transfection Using Ultrasoundmediated Microbubble Destruction超声微泡介导反义磷酸受纳蛋白基因转染效应的研究
10.The expressions of G protein-coupled receptor 30 and phosphorylated AKT in endometrial adenocarcinomaG蛋白偶联受体30和磷酸化AKT在子宫内膜腺癌中表达及意义
11.Analysis of Conformation Change of Cortactin Oncoprotein in Response to Tyrosine Phosphorylation by Fluorescence Resonance Energy Transfer皮层蛋白受磷酸化调控机制的荧光共振能量转移分析
12.Experimental studies of recombinant human β2-glycoprotein-1 as oral tolerogen in antiphospholipid antibody syndrome重组人β2糖蛋白1作为抗磷脂抗体综合征口服耐受原的实验研究
13.Effects of Exercise on Expression of Phopholamban in the Myocardium Cells of Type 1 Diabetes Mellitus Rat运动对1型糖尿病大鼠心肌细胞中磷酸受纳蛋白表达的影响
14.Analysis of Mouse Connexin31 Phosphorylation Sites小鼠Connexin31蛋白磷酸化定位
15.Study on the Polymorphisms in the Gene for LDL Receptor-Related Protein and ATP-Binding Cassette Transporter-1 in Patients with Premature Coronary Heart Disease;早发冠心病低密度脂蛋白受体相关蛋白与腺苷三磷酸结合盒转运体A1的基因多态性
16.A protein found in egg yolk.卵黄磷蛋白存在卵黄的一种蛋白质
17.Study on physico-chemical property of phosvitin phosphopeptides卵黄高磷蛋白磷酸肽的理化性质研究
18.Any of a group of proteins, such as casein, containing chemically bound phosphoric acid.磷蛋白,磷朊一组蛋白质中的任一个,如酪蛋白,化学上含有稳定的磷酸
相关短句/例句

Phospholamban磷酸受纳蛋白
1.Recent data demonstrate that phospholamban (PLB) is a key regulator of cardiac contractility.最近的研究表明磷酸受纳蛋白(Phospholamban,PLB)是心肌收缩的关键性调节蛋白,位于肌浆网,通过调控肌浆网Ca~(2+)-ATP酶(sarco(endo)plasmic reticulum Ca~(2+)-ATPase,SERCA)对Ca~(2+)的亲和性,影响细胞内游离钙的浓度而影响心肌收缩力。
2.Objective:In this study,we investigated the effect of atorvastatin on cardiac function inspontaneously hypertensive rats(SHRs),focusing in particular on its impact on theexpression of myocardium Ca~(2+)-regulating proteins:sarcoplasmic reticulum Ca~(2+)-adenosine triphosphatase(SERCA),phospholamban(PLB)and its phosphorylated form(phosphorylated PLB).目的:本课题研究atorvastatin对自发性高血压大鼠(spontaneously hypertensive rat,SHR)左心功能的影响,主要关注药物对心肌组织钙调节蛋白的作用,包括肌浆网Ca~(2+)-ATP酶SERCA(sarcoplasmic reticulum Ca~(2+)-adenosine triphosphatase),磷酸受纳蛋白PLB(phospholamban)以及磷酸化PLB(phosphorylated PLB)。
3)phospholamban gene受磷蛋白基因
4)phopholamban磷酸受钠蛋白
5)nucleophosmin核磷蛋白
1.Effect of type A mutant of nucleophosmin on proliferation of myelocytic leukemia cell lines;核磷蛋白A型突变体对髓性白血病细胞系增殖的影响
6)Phosphoproteins磷蛋白类
延伸阅读

普通免疫球蛋白 ,人血丙种球蛋白,丙种球蛋白药物名称:丙种球蛋白英文名:γ-Globulin别名: 免疫血清球蛋白;普通免疫球蛋白 ,人血丙种球蛋白,丙种球蛋白外文名:γ-Globulin 适应症: 含有健康人群血清所具有的各种抗体,因而有增强机体抵抗力以预防感染的作用。主要用于免疫缺陷病以及传染性肝炎、麻疹、水痘、腮腺炎、带状皰疹等病毒感染和细菌感染的防治,也可用于哮喘、过敏性鼻炎、湿疹等内源性过敏性疾病。 用量用法: 肌注:每次2~5ml,3周1次,用于内源性过敏性疾病,每次10ml(含量10%者),3周内注射2次。胎盘球蛋白每次6~9ml。 注意事项: 1.按球蛋白来源可分为两种,一为健康人静脉血来源的丙种球蛋白制剂,按蛋白质含量有10%、16%、16.5%等数种(国内制品浓度在10%以上),其中丙种球蛋白占95%以上。另一种为胎盘血来源的丙种球蛋白(人胎盘血丙种球蛋白),即胎盘球蛋白,含蛋白质5%,其中丙种球蛋白占90%以上。胎盘球蛋白因丙种球蛋白含量以及纯度均较低,其用量应相应增大。 2.除专供静注用的制剂外,一般制剂不可静注。 3.注射大量时,可见局部疼痛和暂时性体温升高。 注:参见:“丙种球蛋白注射液”. 类别:免疫增强剂(免疫反应调节剂)